Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Curcumin in Advanced Cancer
NCT02138955Phase 2Completed
- Sponsor
- SignPath Pharma
- Start
- Mar 2014
- Primary completion
- Nov 2017
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal curcumin in solid tumor, sponsored by SignPath Pharma. Started Mar 2014; status: completed.
02
Drugs
liposomal curcumin
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02138955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02138955.